• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

23andMe

Illustration connected puzzle pieces with the acronym MA
Finance

Healthcare Dealmakers—OHSU and Legacy Health call off merger

CVS picking up hundreds of pharmacies from Rite Aid, New Mountain Capitals' three-way portfolio merger and more M&A news from the month of May.
Dave Muoio Jun 5, 2025 7:30am
DNA strand
Favicon Fierce Biotech

Regeneron’s $256M bid wins 23andMe bankruptcy auction

May 19, 2025 10:37am
close-up of a microbiological pipette in the genetic laboratory

23andMe bankruptcy sparks genetic data privacy concerns

Mar 25, 2025 4:54pm
Two injectable medications with a tape measure wrapped around them

23andMe jumps into GLP-1 weight loss wave

Aug 12, 2024 4:00pm
downtown Austin Texas

SXSW 2023 healthcare recap: AI, genomics and health equity

Mar 17, 2023 2:00pm
23andM3 executive ring the Nasdaq opening bell on the day the company goes public

23andMe betting big on genomic service, therapeutics business

Oct 25, 2022 8:02am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings